L. Pendyala et al., EFFECT OF GLUTATHIONE DEPLETION ON THE CYTOTOXICITY OF CISPLATIN AND IPROPLATIN IN A HUMAN-MELANOMA CELL-LINE, Cancer chemotherapy and pharmacology, 40(1), 1997, pp. 38-44
Previous studies from our laboratory have indicated that glutathione (
GSH) may affect the cytotoxicity of iproplatin to a greater extent tha
n four other platinum agents tested including cisplatin. Therefore we
studied the effect of GSH depletion by buthionine sulfoximine (BSO) on
the cytotoxicity of iproplatin and cisplatin in a human melanoma cell
line SK-MEL-2. Depletion of GSH was dependent on the concentration an
d time of incubation with BSO. BSO (100 mu M) depleted GSH by 85% at 2
4 h and by 91% at 48 h. BSO (10 to 100 mu M) by itself was not cytotox
ic to SK-MEL-2 cells. At 85% depletion of GSH, cytotoxicity of ipropla
tin was increased by a factor of >7 and that of cisplatin by <2. These
results confirm the previous finding that GSH interferes with the cyt
otoxicity of iproplatin to a significantly greater extent than that of
cisplatin. Equitoxic IC65 and IC90 values of cisplatin (2 mu M and 5
mu M) or iproplatin (25 mu M and 50 mu M) had no effect on the intrace
llular GSH levels in SK-MEL-2 cells. Also, depletion of GSH by BSO had
no effect on the accumulation of platinum from either cisplatin or ip
roplatin in this cell line. Our results suggest that the effect of GSH
on the cytotoxicity of cisplatin and iproplatin in this cell line was
not a consequence either of differences in GSH-Pt conjugate formation
, or of differences in platinum accumulation induced by GSH depletion.
GSH may have modulated the cytotoxicity of these platinum complexes b
y other means such as effects on DNA repair, apoptosis, free radical s
cavenging or through other yet unidentified mechanisms.